PMID- 21676609 OWN - NLM STAT- MEDLINE DCOM- 20111107 LR - 20210212 IS - 1879-0429 (Electronic) IS - 0958-1669 (Linking) VI - 22 IP - 4 DP - 2011 Aug TI - Polymer therapeutics as nanomedicines: new perspectives. PG - 492-501 LID - 10.1016/j.copbio.2011.05.507 [doi] AB - A growing number of polymer therapeutics have entered routine clinical use as nano-sized medicines. Early products were developed as anticancer agents, but treatments for a range of diseases and different routes of administration have followed--recently the PEGylated-anti-TNF Fab Cimzia(R) for rheumatoid arthritis and the PEG-aptamer Macugen(R) for age related macular degeneration. New polymer therapeutic concepts continue to emerge with a growing number of conjugates entering clinical development, for example PEGylated-aptamers and a polymer-based siRNA delivery system. 'Hot' topics of the past 2 years include; emerging issues relating to polymer safety, the increasing use of biodegradable polymers, design of technologies for combination therapy, potential biomarkers for patient individualisation of treatment and Regulatory challenges for 'follow-on/generic' polymer therapeutics. CI - Copyright (c) 2011 Elsevier Ltd. All rights reserved. FAU - Duncan, Ruth AU - Duncan R AD - Polymer Therapeutics Lab., Centro de Investigacion Principe Felipe, Av. Autopista del Saler 16 E-46012, Valencia, Spain. LA - eng PT - Journal Article PT - Review DEP - 20110614 PL - England TA - Curr Opin Biotechnol JT - Current opinion in biotechnology JID - 9100492 RN - 0 (Antineoplastic Agents) RN - 0 (Polymers) SB - IM MH - Animals MH - Antineoplastic Agents/therapeutic use MH - Clinical Trials as Topic MH - *Drug Design MH - Humans MH - Nanomedicine/*methods MH - Polymers/chemistry/*therapeutic use EDAT- 2011/06/17 06:00 MHDA- 2011/11/08 06:00 CRDT- 2011/06/17 06:00 PHST- 2011/03/07 00:00 [received] PHST- 2011/05/18 00:00 [revised] PHST- 2011/05/18 00:00 [accepted] PHST- 2011/06/17 06:00 [entrez] PHST- 2011/06/17 06:00 [pubmed] PHST- 2011/11/08 06:00 [medline] AID - S0958-1669(11)00607-0 [pii] AID - 10.1016/j.copbio.2011.05.507 [doi] PST - ppublish SO - Curr Opin Biotechnol. 2011 Aug;22(4):492-501. doi: 10.1016/j.copbio.2011.05.507. Epub 2011 Jun 14.